Haemorrhage of gross domestic product from disability-adjusted-life-years among 15-59 year olds in Kenya

  • Joses Muthuri Kirigia Directorate of Research & School of Health Sciences, Meru University of Science and Technology, Meru, Kenya
  • Germano Mwiga Mwabu School of Economics, University of Nairobi, Nairobi, Kenya

Abstract

Background: This article estimates non-health gross domestic product (GDP) losses associated with Disability-Adjusted Life Years (DALY) lost among 15-59 year olds (most productive age bracket) in Kenya in 2015.


Methods: This study employs the lost output or human capital approach (HCA) to convert the DALYs lost from all causes into their monetary equivalents. The magnitude economic haemorrhage from each disease was obtained by multiplying the per capita non-health GDP in International Dollars by the total number of DALYs lost in a specific age group (15-29 years, 30-49 years, 50-59 years). Per capita non-health GDP equals per capita GDP minus total health expenditure in 2015. Data on DALYs and per capita total health expenditure were obtained from the World Health Organization and per capita GDP data was from IMF databases.


Results: Kenya lost 9,405,184 DALYs among 15-59 years olds in 2015. That DALY loss caused a haemorrhage in GDP of Int$ 29,788,392,419. Approximately 48.6% of the GDP haemorrhage resulted from communicable diseases and nutritional conditions, 37.4% from non-communicable diseases, and 14.0% from injuries.


Conclusion: There is need to augment domestic and external investments into national health systems and other systems that meet basic needs (education, food, water, sanitation, shelter) to reduce disease burden.


Key words: Non-health GDP, economic haemorrhage, disability-adjusted life year (DALY)

Author Biography

Joses Muthuri Kirigia, Directorate of Research & School of Health Sciences, Meru University of Science and Technology, Meru, Kenya

Directorate of Research & School of Health Sciences, Meru University of Science and Technology, Meru, Kenya

References

1. World Health Organization (WHO). Global health estimates
2015: DALYs by cause, age, sex, by country and by region, 20002015.
WHO: Geneva; 2016a.
2. Sambo LG, Kirigia JM. Investing in health systems for universal
health coverage in Africa. BMC International Health and Human
Rights. 2014; 14(28). Available from: http://www.biomedcentral.
com/1472-698X/14/28.
3. Sambo LG, Kirigia JM, Orem JN. Health financing in the African
Region: 2000-2009 data analysis. International Archives of
Medicine. 2013; 6(10). Available from: http://www.intarchmed.
com/content/6/1/10.
4. WHO. Commission on social determinants of health final report.
Geneva: WHO; 2008a.
5. Mwabu GM, Ajakaiye O. Reproductive health, economic growth
and poverty reduction in Africa. Nairobi: University of Nairobi
Press; 2013.
6. Kirigia JM, Ota MO, Senkubuge F, Wiysonge CS, Mayosi
BM. Developing the African national health research systems
barometer. Health Research Policy and Systems. 2016a; 14
(53). Available from: http://www.health-policy-systems.com/
content/14/1/53.
7. Kirigia JM, Ota MO, Motari M, Bataringaya JE, Mouhouelo P.
National health research systems in the WHO African Region:
current status and the way forward. Health Research Policy and
Systems. 2015a; 13(61). Available from: http://www.health-
policy-systems.com/content/13/1/61
8. Kirigia JM, Sambo LG, Aldis W, Mwabu G. Impact of disasterrelated
mortality on gross domestic product in the WHO African
Region. BMC Emergency Medicine. 2004; 4(1). Available from:
http://www.biomedcentral.com/1471-227X/4/1.
9. Kirigia JM, Oluwole D, Gatwiri D, Kainyu LH. Effects of maternal
mortality on gross domestic product (GDP) in the WHO African
Region. African Journal of Health Sciences. 2006; 13(1-2): 8695.
10. Kirigia JM, Sambo HB, Sambo LG, Barry SP. Economic burden of
diabetes mellitus in the WHO African region. BMC International
Health and Human Rights. 2009a; 9(6). Available from: http://
www.biomedcentral.com/1472-698X/9/6.
11. Kirigia JM, Sambo LG, Yokouide A, Soumbey-Alley E, Muthuri
LK, Kirigia DG. Economic burden of cholera in the WHO African
region. BMC International Health and Human Rights. 2009b;
9(8). Available from: http://www.biomedcentral.com/1472698X/9/8.
12. Okorosobo F, Mwabu G, Orem JN, Kirigia JM. Economic burden
of malaria in five countries of Africa. European Journal of
Business and Management. 2011; 3(6): 42-62.
13. Orem JN, Kirigia JM, Azairwe R, Kasirye I, Walker O. Impact
of malaria morbidity on gross domestic product in Uganda.
International Archives of Medicine. 2012; 5(12). Available from:
http://www.intarchmed.com/content/5/1/12.
14. Kirigia JM, Mwabu GM, Orem JN, Muthuri RDK. Indirect cost
of maternal deaths in the WHO African Region in 2010. BMC
Pregnancy and Childbirth. 2014; 14(299). Available from: http://
www.biomedcentral.com/1471-2393/14/299.
15. Kirigia JM, Muthuri RDK, Nabyonga-Orem J, Kirigia DW. Counting
the cost of child mortality in the World Health Organization
African region. BMC Public Health. 2015b; 15(1103). Available
from: http://www.biomedcentral.com/content/pdf/s12889015-2465-z.pdf.
16. Kirigia JM, Masiye F, Kirigia DW, Akweongo P. Indirect costs
associated with deaths from the Ebola virus disease in West
Africa. Infectious Diseases of Poverty. 2015c; 4(45). Available
from: http://www.idpjournal.com/content/4/1/45.
17. Kirigia JM, Muthuri RDK. Productivity losses associated with
tuberculosis deaths in the World Health Organization African
Region. Infectious Diseases of Poverty. 2016; 5(43). Available
from: https://idpjournal.biomedcentral.com/articles/10.1186/
s40249-016-0138-5.
18. Kirigia JM, Mwabu GM, Orem JN, Muthuri RDK. Indirect cost of
maternal deaths in the WHO African Region, 2013. International
Journal of Social Economics. (2016b); 43(5): 532 - 548.
19. Kirigia JM, Mwabu GM, M'Imunya JM, Muthuri RDKM, Nkanata
LHK, Gitonga EB. Indirect cost of non-communicable diseases
deaths in the World Health Organization African Region.
International Archives of Medicine. 2017a; 10(34). Available
from: http://imedicalsociety.org/ojs/index.php/iam/article/
view/2400
20. Kirigia JM, Mburugu GN, Huka GS. The indirect cost of disability
adjusted life years lost among the elderly in Kenya. International
Archives of Medicine. 2017b; 10(248). Available from: http://
imedicalsociety.org/ojs/index.php/iam/article/view/2577
21. Petty W. Political arithmetrick, or a discourse concerning the
extent and value of lands, people, buildings, etc. London: Robert
Caluel; 1699.
22. Mushkin SJ, Collings FA. Economic costs of disease and injury.
Public Health Reports. 1959; 74: 795-809.
23. Landefeld JS, Seskin EP. The economic value of life: linking
theory to practice. American Journal of Public Health. 1982; 72:
555-566.
24. Weisbrod BA. Costs and benefits of medical research: a case
study of poliomyelitis. Journal of Political Economy. 1971; 79:
527-544.
25. Murray CJL. Quantifying the burden of disease: the technical
basis for disability-adjusted life years. Bulletin of the World
Health Organization. 1994; 72: 427-445.
26. Struijk EA, May AM, Beulens JWJ, de Wit GA, Boer JMA,
Onland-Moret NC, van der Schouw YT, Bueno-de-Mesquita
HB, Hoekstra J, Peeters PHM. Development of methodology for
disability-adjusted life years (DALYs) calculation based on reallife
data. PLoS ONE. 2013; 8(9): e74294. Available from: https://
doi.org/10.1371/journal.pone.0074294
27. WHO. WHO methods and data sources for global burden of
disease 2000-2015. Global health estimates technical paper
WHO/HIS/HSI/GHE/2017.1. Geneva: WHO; 2017a.
28. International Monetary Fund (IMF). World economic outlook
database. Washington, D.C.: IMF; 2016. Available from:
http://www.imf.org/external/pubs/ft/weo/2015/02/weodata/
weorept.aspx? Accessed on 7 February 2017 at 15h30.
29. WHO. Global health expenditure database. Geneva: WHO;
2017b. Available from: http://apps.who.int/nha/database/
Select/Indicators/en accessed on 11 February 2017 at 14h51.
30. WHO. Global health sector strategies on HIV, viral hepatitis and
sexually transmitted infections, for the period 2016-2021. World
Health Assembly resolution WHA69.22. Geneva: WHO; 2016b.
31. WHO. Global health sector strategy on HIV, 2016-2021: towards
ending AIDS. Document WHO/HIV/2016.05. Geneva: WHO;
2016c.
32. World Health Organization Regional Office for Africa (WHO/
AFRO). HIV/AIDS: strategy for the African region. WHO Regional
Committee for Africa resolution AFR/RC62/R2. Brazzaville:
WHO; 2012a.
33. WHO. Control of diarrhoeal diseases. WHA Resolution WHA
31.44. Geneva: WHO; 1978.
34. WHO. Diarrhoeal diseases control. World Health Assembly
(WHA) resolution WHA40.34. Geneva: WHO; 1987.
35. WHO. Cholera: mechanism for control and prevention. WHA
Resolution WHA64.15. Geneva: WHO; 2011a.
36. WHO. Emergencies preparedness, response, Cholera - Kenya,
disease outbreak news, 21 July 2017. WHO, Geneva: WHO;
2017c. Available at: http://www.who.int/csr/don/21-july-2017cholera-kenya/en/
accessed on 19th August 2017 at 14h51.
37. WHO. Global vector control response: an integrated approach
for the control of vector-borne diseases. WHA Resolution
WHA70.16. Geneva: WHO; 2017d.
Published
2018-03-24
How to Cite
KIRIGIA, Joses Muthuri; MWABU, Germano Mwiga. Haemorrhage of gross domestic product from disability-adjusted-life-years among 15-59 year olds in Kenya. International Archives of Medicine, [S.l.], v. 11, mar. 2018. ISSN 1755-7682. Available at: <http://imedicalsociety.org/ojs/index.php/iam/article/view/2783>. Date accessed: 15 oct. 2018. doi: https://doi.org/10.3823/2561.
Section
Global Health & Health Policy

Most read articles by the same author(s)